Novavax Stock News

The company reported some good news in an important Asian market.

SEOUL, Nov. 15 (Yonhap) -- South Korea will review local drugmaker SK Bioscience Co.''s request to manufacture and sell Novavax COVID-19 vaccine here, the drug safety agency said Monday. Last year, the affiliate under SK Group signed a deal with the

NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (KSF) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 11, 2022 to file lead plaintiff applications in a securities class action lawsuit against Novavax, Inc. (NasdaqGS: NVAX), if they purchased the Companys securities between March 2, 2021 and October 19, 2021, inclusive (the Class Period). This action is pending in the United States District Court for the Dis

(PR-inside.com) NEW YORK, NY / ACCESSWIRE / November 15, 2021 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Novavax, Inc. ("Novavax" or the "Company") (NASDAQ:NVAX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Novavax between March 2, 2021 and October 19, 2021, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm''s site: www.bgandg.com/nvax. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The complaint alleges that ..

Covovax has been developed by Novavax and is being manufactured by the Pune-based SII, but is not cleared for emergency use in India.

(RTTNews) - Novavax Inc. (NVAX) said that SK bioscience has summited a biologics license application for NVX-CoV2373, the first protein-based COVID-19 vaccine candidate, to South Korea''s Ministry of Food and Drug Safety. NVX-CoV2373 is Novavax'' recombinant nanoparticle COVID-19 vaccine with Matrix-M adjuvant. In collaboration with Novavax, SK

SK bioscience submits application for NVX-CoV2373, the first protein-based COVID-19 vaccine candidate for BLA, to South Korea''s MFDS GAITHERSBURG, Md., Nov. 15, 2021 /PRNewswire/ -- Novavax, Inc.

Sources familiar with Liam Jones situation said hed been given significant information on vaccination by the Blues and was offered the opportunity to go on the inactive list, rather than retire outright.

Maryland-based biotech company Novavax could soon bring a new coronavirus vaccine into the market about a year after Americans first rolled up their sleeves.

Metropolitan Life Insurance Co NY raised its position in shares of Novavax, Inc. (NASDAQ:NVAX) by 31,862.5% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,114 shares of the biopharmaceutical companys stock after purchasing an additional 5,098 shares during the quarter. Metropolitan Life Insurance []